Short Acting Insulin

Diabetes Medication Article

Types of Insulin

There are more than 20 types of insulin products available in four basic forms, each with a different time of onset and duration of action. The decision as to which insulin to choose is based on an individual's lifestyle, a physician's preference and experience, and the person's blood sugar levels. Among the criteria considered in choosing insulin are:

how soon it starts working (onset)
when it works the hardest (peak time)
how long it lasts in the body (duration)

The insulin products used by people with diabetes are either taken from animals (pigs or cows) or manufactured in labs to be identical to human insulin. Beef insulin is no longer available in the United States. Beginning in January 2006, pork insulin for human use will no longer be manufactured or marketed in the U.S.

Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat

Short Acting Insulin News

Short acting Insulin

Go to the new RSS page and renew your subscription.]]>

IMPORTANT: Bing News RSS feed has moved!

Diabetes is among the top ten leading causes of death in the U.S. Insulin pumps deliver rapid- or short-acting insulin throughout the day via a catheter rather than require a person or caregiver to do periodic injections.

FDA warns J & J on insulin pumps

Bydureon is basically short-acting exenatide (also known as Byetta ®) that is ... These drugs work like GLP-1 in the body: They improve insulin secretion, they lower blood glucose levels, they lower glucagon levels, and they help patients ...

Bydureon: An Easy, Effective New Treatment for Type 2 Diabetes

As a general guide, decrease insulin dose that will peak during planned exercise. This may be long or short acting insulin. Hypoglycemia is more common in Type I diabetics, especially if dosing insulin multiple times per day. Symptoms of hypoglycemia ...

Diabetes is on the rise, so is the sport of triathlon

The MKC-171 trial has been designed with FDA guidance not only to demonstrate that two inhalers (an early generation and more recent model) are equivalent in a clinical setting, but also to show that AFREZZA is superior to widely-used short-acting insulin ...

Why MannKind Should Merit Your Attention

Afrezza is the first ultra-fast-acting insulin, a new class of prandial insulins ... MSMB is a hedge fund notorious for short selling stocks of early stage public biopharmaceutical companies. Shkreli often publishes negative reports on companies ...

The Details of the Afrezza Approval Delay

Depending on the timing of the onset, various types of insulin are available. These are classified as short-acting, intermediate acting and long-acting insulin. In addition, there are rapidly-acting and slow-acting insulin analogues. Availability of ...

Diabetes in children

... or Lantus® (insulin glargine), which is a long-acting insulin. BYETTA is not insulin and should not be taken instead of insulin. BYETTA should not be taken with short- and/or rapid-acting insulin. BYETTA is not for people with type 1 ...

FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes

AFREZZA is a novel, ultra rapid-acting mealtime insulin therapy in late stage clinical investigation ... Could it be the massive short interest of 28 million shares? (And only heaven knows how many more shares are short due to manipulative ...

The Curious Case Of MannKind Corporation

... thiazolidinedione or Lantus (insulin glargine), which is a long-acting insulin. BYETTA is not insulin and should not be taken instead of insulin. BYETTA should not be taken with short- and/or rapid-acting insulin. BYETTA is not for people with type 1 ...